Company: CGCT
Filing Date: 2025-01-29
Form Type: S-1
Source: 0001104659-25-006780
Chunk: 121

Company: Cartesian Growth Corp III
Filing Date: 2025-01-29
Form: S-1
Chunk 121
---
 management team and board of directors have had significant experience as founders, board members, officers, executives or employees
of other companies. Certain of those persons have been, are currently or may in the future become involved in litigation, investigations
or other proceedings, including relating to the business affairs of such companies, transactions entered into by such companies, or otherwise.
Any such litigation, investigations or other proceedings may divert the attention and resources of our management team and board of directors
away from identifying and selecting a target business or businesses for our initial business combination and may negatively affect our
reputation, which may impede our ability to complete an initial business combination.

Members of our management team and affiliated companies may have been, and may in the future be, involved in civil disputes or governmental investigations unrelated to our business.

Members of our management team have been (and
intend to be) involved in a wide variety of businesses. Such involvement has, and may lead to, media coverage and public awareness. As
a result, members of our management team and affiliated companies may have been, and may in the future be, involved in civil disputes
or governmental investigations unrelated to our business. Any such claims or investigations may be detrimental to our reputation and could
negatively affect our ability to identify and complete an initial business combination and may have an adverse effect on the price of
our securities.

Our letter agreements with our initial shareholders, officers and directors may be amended without shareholder approval.

Our letter agreements with our initial shareholders,
officers and directors contain provisions relating to transfer restrictions of our founder shares and private placement warrants, indemnification
of the trust account, waiver of redemption rights and participation in liquidating distributions from the trust account. The letter agreements
may be amended without shareholder approval (although releasing the parties from the restriction not to transfer the founder shares or
private placement warrants for 180 days following the date of this prospectus will require the prior written consent of the underwriters).
While we do not expect our board to approve any amendment to the letter agreements prior to our initial business combination, it may be
possible that our board, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or more amendments
to the letter agreements. Any such amendments to the letter agreements would not require approval from our shareholders and may have an
adverse effect on the value of an investment in our securities.

<div align='center'>67</div>

Risks Relating to our Securities

You will not have any rights or interests